Get the Stockscreener App
326.85
2.59%
8.26
After Hours:
327.66
0.81
+0.25%
Insulet Corporation stock is traded at $326.85, with a volume of 373.80K.
It is up +2.59% in the last 24 hours and down -1.21% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
See More
Previous Close:
$318.59
Open:
$318.12
24h Volume:
373.80K
Relative Volume:
0.61
Market Cap:
$23.01B
Revenue:
$2.36B
Net Income/Loss:
$236.10M
P/E Ratio:
99.47
EPS:
3.286
Net Cash Flow:
$382.50M
1W Performance:
+3.91%
1M Performance:
-1.21%
6M Performance:
+32.44%
1Y Performance:
+38.15%
1-Day Range:
$318.12
$326.88
1-Week Range:
$312.05
$326.88
52-Week Range:
$226.50
$353.50
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
326.85 | 22.43B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
129.51 | 223.72B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
100.53 | 147.05B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
381.22 | 143.14B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.92 | 122.86B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.29 | 43.82B | 5.69B | 1.41B | 577.90M | 6.9828 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Resumed | Oppenheimer | Outperform |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| May-13-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-29-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-06-25 | Initiated | RBC Capital Mkts | Outperform |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Stifel Bullish on Insulet (PODD) with Positive Outlook - GuruFocus
Why Insulet Corporation (GOV) stock could break out in 2025Weekly Investment Recap & Community Verified Trade Alerts - newser.com
Insulet Corporation (PODD) Sees Higher 2025–2026 Revenue and Operating Margins, Says Canaccord - Insider Monkey
Will Insulet Corporation outperform the marketOil Prices & Short-Term High Return Ideas - newser.com
Advanced analytics toolkit walkthrough for Insulet CorporationWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Will Insulet Corporation (GOV) stock deliver compounding returnsJuly 2025 Rallies & Stock Portfolio Risk Management - nchmf.gov.vn
Avoiding Lag: Real-Time Signals in (PODD) Movement - news.stocktradersdaily.com
Pattern recognition hints at Insulet Corporation upsideJuly 2025 Catalysts & Real-Time Market Trend Scan - newser.com
Why analysts remain bullish on Insulet Corporation stockEarnings Overview Report & Free Technical Pattern Based Buy Signals - newser.com
Book value per share of Insulet Corporation – DUS:GOV - TradingView
How to monitor Insulet Corporation with trend dashboardsJuly 2025 Breakouts & Capital Protection Trading Alerts - newser.com
Published on: 2025-10-19 02:33:04 - nchmf.gov.vn
Is Insulet Corporation stock a buy for dividend growth2025 Technical Patterns & Verified Technical Trade Signals - nchmf.gov.vn
Insulet Corporation (PODD) Stock forecasts - Yahoo
Why Insulet Corporation stock is favored by top institutions2025 Volatility Report & AI Forecast Swing Trade Picks - nchmf.gov.vn
Published on: 2025-10-18 07:37:01 - nchmf.gov.vn
Lobbying Update: $110,000 of INSULET CORPORATION lobbying was just disclosed - Quiver Quantitative
Is Insulet Corporation GOV a good long term investmentTrading Psychology Tips & Low Entry Investment Portfolio - earlytimes.in
Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Insulet Corporation stock could outperform in 2025Market Trend Report & Weekly Market Pulse Alerts - newser.com
What Fibonacci levels say about Insulet Corporation reboundChart Signals & Safe Entry Point Alerts - newser.com
Full technical analysis of Insulet Corporation stockOptions Play & High Accuracy Swing Trade Signals - newser.com
Long term hold vs stop loss in Insulet CorporationMarket Movers & Real-Time Buy Zone Alerts - newser.com
Truist Securities Reiterates Buy Rating on Insulet (PODD) Stock - MSN
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Leerink Partners Adjusts Price Target on Insulet to $355 From $339, Maintains Outperform Rating - MarketScreener
Is Now The Time To Look At Buying Insulet Corporation (NASDAQ:PODD)? - 富途牛牛
Insulet (PODD) Valuation in Focus as Omnipod 5 Adoption Fuels Growth and Investor Optimism - Sahm
Insulet to Host Investor Day on November 20, 2025 - MarketScreener
Lobbying Update: $50,000 of INSULET CORPORATION lobbying was just disclosed - Quiver Quantitative
Insulet names new CEO, plans to lift full year guidance - MSN
Fifth Third Wealth Advisors LLC Invests $448,000 in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Sold by Aberdeen Group plc - MarketBeat
Insulet Corporation (PODD) Stock Analysis: Exploring a 15.3% Potential Upside with Robust Growth Prospects - DirectorsTalk Interviews
How to interpret RSI for Insulet Corporation stockEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Insulet Corporation stock trend outlook and recovery pathDividend Hike & Long-Term Growth Plans - newser.com
Insulet Corp. stock underperforms Tuesday when compared to competitors - MSN
Royal Bank Of Canada Raises Insulet (NASDAQ:PODD) Price Target to $365.00 - MarketBeat
Katamaran Capital LLP Has $1.22 Million Stock Position in Insulet Corporation $PODD - MarketBeat
Insulet (PODD) Valuation: Is There More Room to Run After 22% YTD Gain? - Yahoo Finance
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
What MACD signals say about Insulet CorporationJuly 2025 EndofMonth & Community Consensus Stock Picks - newser.com
What RSI levels show for Insulet Corporation (GOV) stockQuarterly Profit Summary & Daily Volume Surge Signals - newser.com
RBC Lifts Price Target on Insulet to $365 From $350, Keeps Outperform Rating - MarketScreener
Blair William & Co. IL Sells 13,724 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):